GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » DaShenLin Pharmaceutical Group Co Ltd (SHSE:603233) » Definitions » Net Income Including Noncontrolling Interests

DaShenLin Pharmaceutical Group Co (SHSE:603233) Net Income Including Noncontrolling Interests : ¥1,160 Mil (TTM As of Mar. 2024)


View and export this data going back to 2017. Start your Free Trial

What is DaShenLin Pharmaceutical Group Co Net Income Including Noncontrolling Interests?

Net Income Including Noncontrolling Interests is the net income of the group after the adjustment of all expenses and benefit. It includes the net income (loss) attributable to noncontrolling and redeemable noncontrolling interests and the net income (loss) attributable to the company.

DaShenLin Pharmaceutical Group Co's Net Income Including Noncontrolling Interests for the three months ended in Mar. 2024 was ¥454 Mil. Its Net Income Including Noncontrolling Interests for the trailing twelve months (TTM) ended in Mar. 2024 was ¥1,160 Mil.

DaShenLin Pharmaceutical Group Co Net Income Including Noncontrolling Interests Historical Data

The historical data trend for DaShenLin Pharmaceutical Group Co's Net Income Including Noncontrolling Interests can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

DaShenLin Pharmaceutical Group Co Net Income Including Noncontrolling Interests Chart

DaShenLin Pharmaceutical Group Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Net Income Including Noncontrolling Interests
Get a 7-Day Free Trial Premium Member Only Premium Member Only 696.54 1,083.02 804.40 1,079.27 1,230.66

DaShenLin Pharmaceutical Group Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Net Income Including Noncontrolling Interests Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 524.26 429.72 268.63 8.06 453.69

DaShenLin Pharmaceutical Group Co Net Income Including Noncontrolling Interests Calculation

Net Income Including Noncontrolling Interests is the net income of the group after the adjustment of all expenses and benefit. It includes the net income (loss) attributable to noncontrolling and redeemable noncontrolling interests and the net income (loss) attributable to the company.

Net Income Including Noncontrolling Interests for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥1,160 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

DaShenLin Pharmaceutical Group Co Net Income Including Noncontrolling Interests Related Terms

Thank you for viewing the detailed overview of DaShenLin Pharmaceutical Group Co's Net Income Including Noncontrolling Interests provided by GuruFocus.com. Please click on the following links to see related term pages.

DaShenLin Pharmaceutical Group Co (SHSE:603233) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » DaShenLin Pharmaceutical Group Co Ltd (SHSE:603233) » Definitions » Net Income Including Noncontrolling Interests
Comparable Companies
SZSE:002653 SHSE:688520 SZSE:301301 SHSE:688278 SZSE:301207 SZSE:300009 SZSE:000403 SHSE:688578 SHSE:688166 SHSE:688639 OCSE:NOVO B VRTX REGN ASX:CSL SGEN XKRX:207940 MRNA HKSE:02269 XBRU:ARGX BNTX
Traded in Other Exchanges
N/A
Address
No. 410-1, Longxi Avenue, Liwan District, Guangdong Province, Guangzhou, CHN, 510000
Website
http://www.dslyy.com
DaShenLin Pharmaceutical Group Co Ltd is engaged in the pharmaceutical manufacturing, retail and wholesale business. The company is based on the development of the pharmacy chain. It primarily offers Chinese herbal medicine such as antibiotics and biochemical drugs. The business activities are geographically carried out through China.

DaShenLin Pharmaceutical Group Co (SHSE:603233) Headlines

No Headlines